CVE:VIR Viridium Pacific Group (VIR) Stock Price, News & Analysis C$0.38 +0.02 (+5.56%) As of 06/7/2019 Add Compare Share Share Stock Analysis Stock Analysis About Viridium Pacific Group Stock (CVE:VIR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Viridium Pacific Group alerts:Sign Up Key Stats Today's RangeC$0.37▼C$0.4150-Day RangeC$0.38▼C$0.3852-Week RangeC$0.36▼C$1.15Volume26,500 shsAverage Volume92,632 shsMarket CapitalizationC$37.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewViridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.Read More… Receive VIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viridium Pacific Group and its competitors with MarketBeat's FREE daily newsletter. Email Address VIR Stock News HeadlinesOrchids Are Highly Prized in the West. In the South Pacific, They’re Everywhere.November 14, 2024 | nytimes.comPacific American Holdings Acquires High-Grade Silver ProjectOctober 28, 2024 | msn.comBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chipmaker has struggled this year, facing increased competition and regulatory pressure.March 4, 2025 | Chaikin Analytics (Ad)Pacific American Holdings Acquires Promising Silver ProjectOctober 25, 2024 | markets.businessinsider.comPacific Urban Investors acquires Cupertino apartmentsOctober 22, 2024 | bizjournals.comSRG launches Asia Pacific division in SingaporeOctober 17, 2024 | msn.comUS Pacific Ally Intercepts Russian Naval GroupOctober 10, 2024 | msn.comMcDavid and Oilers top a Pacific Division that features a mix of contending and rebuilding teamsOctober 2, 2024 | washingtonpost.comSee More Headlines VIR Stock Analysis - Frequently Asked Questions How have VIR shares performed this year? Viridium Pacific Group's stock was trading at C$0.38 on January 1st, 2025. Since then, VIR stock has increased by 0.0% and is now trading at C$0.38. View the best growth stocks for 2025 here. How do I buy shares of Viridium Pacific Group? Shares of VIR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Viridium Pacific Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viridium Pacific Group investors own include Baytex Energy (BTE), Allena Pharmaceuticals (ALNA), Abacus Health Products (ABAHF), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS) and Ardelyx (ARDX). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolCVE:VIR CIKN/A Webwww.viridiumpacific.com Phone604-837-8688FaxN/AEmployees580Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio10.28 Quick Ratio9.91 Sales & Book Value Annual SalesC$1.09 million Price / Sales34.46 Cash FlowC$0.13 per share Price / Cash Flow2.92 Book ValueC$0.29 per share Price / Book1.30Miscellaneous Outstanding Shares98,733,000Free FloatN/AMarket CapC$37.52 million OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (CVE:VIR) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridium Pacific Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridium Pacific Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.